Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

March 01, 2019

NOVARTIS PHARMACEUTICALS CORPORATION v. JANSSEN PHARMACEUTICALS COMPANY OF JOHNSON & JOHNSON

Track this case

Case Number:

1:19-cv-00576

Court:

District Of Columbia

Nature of Suit:

Other Statutory Actions

Judge:

John D. Bates

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 25, 2019

    Novartis Settles Suit Saying Janssen Maligned Rival Drug

    Novartis agreed Thursday to settle its D.C. federal lawsuit that accused Janssen of touting skewed study results to make it seem like Janssen's plaque psoriasis treatment, Tremfya, is less dangerous and more effective than Novartis' own Cosentyx.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login